Institute of Cancer Research
The Royal Marsden launches AI radiology platform to revolutionise cancer care
May 27, 2025Analytical & Laboratory Services, Market & Product Development, Medical Education, Research and Development AI, CARPL.ai., Institute of Cancer Research, NTT DATA, National Institute for Health and Care Research, Oncology, The Royal Marsden, oncology, radiology
The Royal Marsden, a world-leading cancer research centre, has launched a large-scale, AI-powered radiology platform designed to accelerate cancer detection …
Cancer drug access for NHS patients is slowing, ICR reports
December 4, 2018Manufacturing and Production, Research and Development, Sales and Marketing Cancer, ICR, Institute of Cancer Research, NHS, NICE, UK, pharma
A new report from the Institute of Cancer Research (ICR) has indicated that NHS patients in the UK are suffering …
Blood test could predict treatment effectiveness months earlier in breast cancer
March 6, 2018Manufacturing and Production, Research and Development Cancer, ICR, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, breast cancer, palbociclib, pharma
A team of scientists at The Institute of Cancer Research in London and The Royal Marsden NHS Foundation Trust have …
New research reveals how cancer cells grow and spread through body
January 6, 2017Medical Communications Cancer, Cancer Research UK, ICR, Institute of Cancer Research, cancer research, cell movement
Research conducted by The Institute of Cancer Research (ICR), co-funded by Cancer Research UK, has discovered how cancer cells are …
Institute of Cancer Research names chief executive
November 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICR, Institute of Cancer Research, paul workman
Professor Paul Workman has been appointed as the chief executive of the Institute of Cancer Research. Workman who also becomes …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
